CDCA5 and prostate cancer: This in consistent with a previous study by Ji et al., which indicated that high CDCA5 expression is associated with poor survival in prostate cancer [45] Furthermore, our functional results suggest that decreasing CDCA5 occurs with an accumulation of cells in the G2/M phase of cell cycle in aggressive tumors.